Paradigm Biocapital Advisors LP - 27 Jan 2025 SCHEDULE 13G Report for Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
EWTX
Shares outstanding
94,778,580 shares
Disclosed Ownership
4,738,929 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
03 Feb 2025, 16:36:27 UTC
Date of event
27 Jan 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Paradigm Biocapital Advisors LP disclosed 5% ownership in Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX) on 27 Jan 2025."

Quick Takeaways

  • Paradigm Biocapital Advisors LP filed SCHEDULE 13G for Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX).
  • Disclosed ownership: 5%.
  • Date of event: 27 Jan 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 03 Feb 2025, 16:36.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5% 4,738,929 4,738,929 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5% 4,738,929 4,738,929 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5% 4,738,929 4,738,929 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.4% 4,181,497 4,181,497 0 /s/ David K. Kim David K. Kim / Authorized Signatory

Sponsored